Acute effects of COREXIT® EC9500A on cardiovascular function

abstract published in 2011
Place scholarly_conference_abstract Q26237364
Press Enter · cited answer in seconds

Summary

Acute effects of COREXIT® EC9500A on cardiovascular function is a scholarly conference abstract[1].

Key Facts

  • Acute effects of COREXIT® EC9500A on cardiovascular function authored Vincent Castranova[2].
  • Acute effects of COREXIT® EC9500A on cardiovascular function authored David G. Frazer[3].
  • Acute effects of COREXIT® EC9500A on cardiovascular function authored Jenny R. Roberts[4].
  • Acute effects of COREXIT® EC9500A on cardiovascular function authored W. Travis Goldsmith[5].
  • Acute effects of COREXIT® EC9500A on cardiovascular function authored Kristine M. Krajnak[6].
  • Acute effects of COREXIT® EC9500A on cardiovascular function authored Hong Kan[7].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's instance of is recorded as scholarly conference abstract[8].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's page is recorded as 1016.2[9].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's DOI is recorded as 10.1096/FASEBJ.25.1_SUPPLEMENT.1016.2[10].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's language of work or name is recorded as English[11].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's issue is recorded as Meeting Abstracts[12].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's volume is recorded as 25[13].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's publication date is recorded as +2011-04-10T00:00:00Z[14].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's sponsor is recorded as NIOSH Health Effects Laboratory Division[15].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as Polysorbate 80[16].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as docusate sodium[17].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as polysorbate 85[18].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as 1-(2-butoxy-1-methylethoxy)propan-2-ol[19].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as sorbitan monooleate[20].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as hydrotreated kerosene[21].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as exposure assessment[22].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as cardiovascular disease[23].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's main subject is recorded as C13-C14 isoparafin[24].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's work available at URL is recorded as https://www.fasebj.org/doi/10.1096/fasebj.25.1_supplement.1016.2[25].
  • Acute effects of COREXIT® EC9500A on cardiovascular function's published in is recorded as FASEB Journal[26].

Body

Designation and Status

Acute effects of COREXIT® EC9500A on cardiovascular function's instance of is recorded as scholarly conference abstract[8].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [8] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  2. [2] ↑ . wikidata.org.
  3. [3] ↑ . NIOSHTIC-2. wikidata.org.
  4. [4] ↑ . NIOSHTIC-2. wikidata.org.
  5. [5] ↑ . NIOSHTIC-2. wikidata.org.
  6. [6] ↑ . NIOSHTIC-2. wikidata.org.
  7. [7] ↑ . NIOSHTIC-2. wikidata.org.
  8. [9] ↑ . NIOSHTIC-2. wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . NIOSHTIC-2. wikidata.org.
  12. [13] ↑ . NIOSHTIC-2. wikidata.org.
  13. [14] ↑ . NIOSHTIC-2. wikidata.org.
  14. [15] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  15. [16] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  16. [17] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  17. [18] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  18. [19] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  19. [20] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  20. [21] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  21. [22] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  22. [23] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  23. [24] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  24. [25] ↑ . NIOSHTIC-2. Retrieved . wikidata.org.
  25. [26] ↑ . NIOSHTIC-2. wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Acute effects of COREXIT® EC9500A on cardiovascular function. Retrieved May 3, 2026, from https://4ort.xyz/entity/acute-effects-of-corexit-ec9500a-on-cardiovascular-function
MLA “Acute effects of COREXIT® EC9500A on cardiovascular function.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/acute-effects-of-corexit-ec9500a-on-cardiovascular-function.
BibTeX @misc{4ortxyz_acute-effects-of-corexit-ec9500a-on-cardiovascular-function_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Acute effects of COREXIT® EC9500A on cardiovascular function}}, year = {2026}, url = {https://4ort.xyz/entity/acute-effects-of-corexit-ec9500a-on-cardiovascular-function}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Acute effects of COREXIT® EC9500A on cardiovascular function — https://4ort.xyz/entity/acute-effects-of-corexit-ec9500a-on-cardiovascular-function (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/acute-effects-of-corexit-ec9500a-on-cardiovascular-function · Last refreshed: